Literature DB >> 116191

Immunological purification and partial characterization of variant-specific surface antigen messenger RNA of Trypanosoma brucei brucei.

M Lheureux, M Lheureux, T Vervoort, N Van Meirvenne, M Steinert.   

Abstract

Polyadenylated RNA isolated from total polyribosomes of two variable antigen types (VATs) of T. brucei brucei were shown to program the synthesis, in mRNA-dependant reticulocyte lysates, of a wide variety of polypeptides. After immunoprecipitation of these cell-free products with an homologous antiserum raised against purified variant-specific surface antigen (VSSA), a major electrophoretic band was apparent on fluorography. It was confirmed that this band corresponds to the variable antigen since only an excess of purified homologous antigen will provoke competition. The apparent molecular weight of the in vitro synthesized antigen is about 63,000 daltons. The VSSA mRNA has been found in membrane-bound polyribosomes and a 15 fold immunological purification of this mRNA has been obtained, using partially purified anti-VSSA IgG in conjunction with inactivated Staphylococcus aureus.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 116191      PMCID: PMC328041          DOI: 10.1093/nar/7.3.595

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  29 in total

1.  Identification, purification and properties of clone-specific glycoprotein antigens constituting the surface coat of Trypanosoma brucei.

Authors:  G A Cross
Journal:  Parasitology       Date:  1975-12       Impact factor: 3.234

Review 2.  Antigenic variation in trypanosomes.

Authors:  G A Cross
Journal:  Proc R Soc Lond B Biol Sci       Date:  1978-06-05

3.  An efficient mRNA-dependent translation system from reticulocyte lysates.

Authors:  H R Pelham; R J Jackson
Journal:  Eur J Biochem       Date:  1976-08-01

4.  [Trypanosoma equiperdum: antigenic variations in experimental trypanosomiasis of rabbits].

Authors:  A Capbern; C Giroud; T Baltz; P Mattern
Journal:  Exp Parasitol       Date:  1977-06       Impact factor: 2.011

5.  Differential translation of turnip yellow mosaic virus mRNAs in vitro.

Authors:  C Benicourt; A L Haenni
Journal:  Biochem Biophys Res Commun       Date:  1978-10-30       Impact factor: 3.575

6.  Bovine leukemia virus: an exogenous RNA oncogenic virus.

Authors:  R Kettmann; D Portetelle; M Mammerickx; Y Cleuter; D Dekegel; M Galoux; J Ghysdael; A Burny; H Chantrenne
Journal:  Proc Natl Acad Sci U S A       Date:  1976-04       Impact factor: 11.205

7.  Purification and properties of rabbit uterus preuteroglobin mRNA.

Authors:  J Arnemann; B Heins; M Beato
Journal:  Nucleic Acids Res       Date:  1977-11       Impact factor: 16.971

8.  Frog oocytes synthesize and completely process the precursor polypeptide to virion structural proteins after microinjection of avian myeloblastosis virus RNA.

Authors:  J Ghysdael; E Hubert; M Trávnícek; D P Bolognesi; A Burny; Y Cleuter; G Huez; R Kettmann; G Marbaix; D Portetelle; H Chantrenne
Journal:  Proc Natl Acad Sci U S A       Date:  1977-08       Impact factor: 11.205

9.  Antigenic variation in trypanosomes.

Authors:  K Vickerman
Journal:  Nature       Date:  1978-06-22       Impact factor: 49.962

10.  A characterization of mRNA activites and their sequence complexities in Trypanosoma brucei: partial purification and properties of the VSSA mRNA.

Authors:  R O Williams; K B Marcu; J R Young; L Rovis; S C Williams
Journal:  Nucleic Acids Res       Date:  1978-09       Impact factor: 16.971

View more
  15 in total

Review 1.  Molecular biology of trypanosome antigenic variation.

Authors:  J E Donelson; A C Rice-Ficht
Journal:  Microbiol Rev       Date:  1985-06

2.  Rapid processing of the carboxyl terminus of a trypanosome variant surface glycoprotein.

Authors:  J D Bangs; D Hereld; J L Krakow; G W Hart; P T Englund
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

3.  Expression of a variant surface glycoprotein of Trypanosoma gambiense in procyclic forms of Trypanosoma brucei shows that the cell type dictates the nature of the glycosylphosphatidylinositol membrane anchor attached to the glycoprotein.

Authors:  F Paturiaux-Hanocq; N Zitzmann; J Hanocq-Quertier; L Vanhamme; S Rolin; M Geuskens; M A Ferguson; E Pays
Journal:  Biochem J       Date:  1997-06-15       Impact factor: 3.857

4.  Purification of low-abundance messenger RNAs from rat liver by polysome immunoadsorption.

Authors:  J P Kraus; L E Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1982-07       Impact factor: 11.205

5.  Analysis of the DNA and RNA changes associated with the expression of isotypic variant-specific antigens of trypanosomes.

Authors:  E Pays; M Lheureux; M Steinert
Journal:  Nucleic Acids Res       Date:  1981-09-11       Impact factor: 16.971

6.  Characterization of the DNA duplication-transposition that controls the expression of two genes for variant surface glycoproteins in Trypanosoma brucei.

Authors:  L H Van der Ploeg; A Bernards; F A Rijsewijk; P Borst
Journal:  Nucleic Acids Res       Date:  1982-01-22       Impact factor: 16.971

7.  Gene duplication and transposition linked to antigenic variation in Trypanosoma brucei.

Authors:  E Pays; N Van Meirvenne; D Le Ray; M Steinert
Journal:  Proc Natl Acad Sci U S A       Date:  1981-05       Impact factor: 11.205

8.  Cloning and characterization of DNA sequences complementary to messenger ribonucleic acids coding for the synthesis of two surface antigens of Trypanosoma brucei.

Authors:  E Pays; M Delronche; M Lheureux; T Vervoort; J Bloch; F Gannon; M Steinert
Journal:  Nucleic Acids Res       Date:  1980-12-20       Impact factor: 16.971

9.  Surface proteins, ERAD and antigenic variation in Trypanosoma brucei.

Authors:  Calvin Tiengwe; Katherine A Muratore; James D Bangs
Journal:  Cell Microbiol       Date:  2016-07-01       Impact factor: 3.715

10.  In vitro synthesis of Trypanosoma cruzi antigenic polypeptides.

Authors:  A M Stolf; C L Santos; R Brentani; M E Camargo
Journal:  Infect Immun       Date:  1983-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.